Updated Analysis Of A Phase I Trial Of Afatinib (Afa) And Bevacizumab (Bev) In Chemo-Naive Patients (Pts) With Advanced Non-Small Cell Lung Cancer (Nsclc) Harboring Egfr-Mutations: Olcsg1404
ANNALS OF ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要